135 related articles for article (PubMed ID: 33247612)
21. [Aprotinin-induced inhibition of pandemic influenza virus A(H1N1) reproduction].
Zhirnov OP; Klenk HD
Vopr Virusol; 2011; 56(3):24-8. PubMed ID: 21786623
[TBL] [Abstract][Full Text] [Related]
22. Low-Dose Carbon Monoxide Inhibits Rhinovirus Replication in Human Alveolar and Airway Epithelial Cells.
Deng X; Yasuda H; Sasaki T; Yamaya M
Tohoku J Exp Med; 2019 Apr; 247(4):215-222. PubMed ID: 30971638
[TBL] [Abstract][Full Text] [Related]
23. Serine protease inhibitors nafamostat mesilate and gabexate mesilate attenuate allergen-induced airway inflammation and eosinophilia in a murine model of asthma.
Chen CL; Wang SD; Zeng ZY; Lin KJ; Kao ST; Tani T; Yu CK; Wang JY
J Allergy Clin Immunol; 2006 Jul; 118(1):105-12. PubMed ID: 16815145
[TBL] [Abstract][Full Text] [Related]
24. TMPRSS2 Is the Major Activating Protease of Influenza A Virus in Primary Human Airway Cells and Influenza B Virus in Human Type II Pneumocytes.
Limburg H; Harbig A; Bestle D; Stein DA; Moulton HM; Jaeger J; Janga H; Hardes K; Koepke J; Schulte L; Koczulla AR; Schmeck B; Klenk HD; Böttcher-Friebertshäuser E
J Virol; 2019 Nov; 93(21):. PubMed ID: 31391268
[TBL] [Abstract][Full Text] [Related]
25. Hemagglutinin Stability Regulates H1N1 Influenza Virus Replication and Pathogenicity in Mice by Modulating Type I Interferon Responses in Dendritic Cells.
Russier M; Yang G; Briard B; Meliopoulos V; Cherry S; Kanneganti TD; Schultz-Cherry S; Vogel P; Russell CJ
J Virol; 2020 Jan; 94(3):. PubMed ID: 31694942
[TBL] [Abstract][Full Text] [Related]
26. Nafamostat-Interferon-α Combination Suppresses SARS-CoV-2 Infection In Vitro and In Vivo by Cooperatively Targeting Host TMPRSS2.
Ianevski A; Yao R; Lysvand H; Grødeland G; Legrand N; Oksenych V; Zusinaite E; Tenson T; Bjørås M; Kainov DE
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578348
[TBL] [Abstract][Full Text] [Related]
27. Transcriptome profiling and protease inhibition experiments identify proteases that activate H3N2 influenza A and influenza B viruses in murine airways.
Harbig A; Mernberger M; Bittel L; Pleschka S; Schughart K; Steinmetzer T; Stiewe T; Nist A; Böttcher-Friebertshäuser E
J Biol Chem; 2020 Aug; 295(33):11388-11407. PubMed ID: 32303635
[TBL] [Abstract][Full Text] [Related]
28. Synergistic Block of SARS-CoV-2 Infection by Combined Drug Inhibition of the Host Entry Factors PIKfyve Kinase and TMPRSS2 Protease.
Kreutzberger AJB; Sanyal A; Ojha R; Pyle JD; Vapalahti O; Balistreri G; Kirchhausen T
J Virol; 2021 Oct; 95(21):e0097521. PubMed ID: 34406858
[TBL] [Abstract][Full Text] [Related]
29. Serine protease inhibitor nafamostat given before reperfusion reduces inflammatory myocardial injury by complement and neutrophil inhibition.
Schwertz H; Carter JM; Russ M; Schubert S; Schlitt A; Buerke U; Schmidt M; Hillen H; Werdan K; Buerke M
J Cardiovasc Pharmacol; 2008 Aug; 52(2):151-60. PubMed ID: 18670364
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of NMDA receptor inhibition by nafamostat, gabexate and furamidine.
Zhigulin AS; Barygin OI
Eur J Pharmacol; 2022 Mar; 919():174795. PubMed ID: 35122868
[TBL] [Abstract][Full Text] [Related]
31. Clinically Relevant Influenza Virus Evolution Reconstituted in a Human Lung Airway-on-a-Chip.
Si L; Bai H; Oh CY; Jin L; Prantil-Baun R; Ingber DE
Microbiol Spectr; 2021 Oct; 9(2):e0025721. PubMed ID: 34523991
[TBL] [Abstract][Full Text] [Related]
32.
Lloren KKS; Kwon JJ; Choi WS; Jeong JH; Ahn SJ; Choi YK; Baek YH; Song MS
J Virol; 2019 Mar; 93(6):. PubMed ID: 30602610
[TBL] [Abstract][Full Text] [Related]
33. Matriptase proteolytically activates influenza virus and promotes multicycle replication in the human airway epithelium.
Beaulieu A; Gravel É; Cloutier A; Marois I; Colombo É; Désilets A; Verreault C; Leduc R; Marsault É; Richter MV
J Virol; 2013 Apr; 87(8):4237-51. PubMed ID: 23365447
[TBL] [Abstract][Full Text] [Related]
34. The host protease TMPRSS2 plays a major role in in vivo replication of emerging H7N9 and seasonal influenza viruses.
Sakai K; Ami Y; Tahara M; Kubota T; Anraku M; Abe M; Nakajima N; Sekizuka T; Shirato K; Suzaki Y; Ainai A; Nakatsu Y; Kanou K; Nakamura K; Suzuki T; Komase K; Nobusawa E; Maenaka K; Kuroda M; Hasegawa H; Kawaoka Y; Tashiro M; Takeda M
J Virol; 2014 May; 88(10):5608-16. PubMed ID: 24600012
[TBL] [Abstract][Full Text] [Related]
35. Nafamostat protects against early brain injury after subarachnoid hemorrhage in mice.
Matsubara H; Imai T; Tsuji S; Oka N; Egashira Y; Enomoto Y; Nakayama N; Nakamura S; Shimazawa M; Iwama T; Hara H
J Pharmacol Sci; 2022 Jan; 148(1):65-72. PubMed ID: 34924132
[TBL] [Abstract][Full Text] [Related]
36. Intravenous peramivir inhibits viral replication, and leads to bacterial clearance and prevention of mortality during murine bacterial co-infection caused by influenza A(H1N1)pdm09 virus and Streptococcus pneumoniae.
Onishi M; Kitano M; Taniguchi K; Homma T; Kobayashi M; Yoshinaga T; Naito A; Sato A
Antiviral Res; 2015 May; 117():52-9. PubMed ID: 25752738
[TBL] [Abstract][Full Text] [Related]
37. TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylate.
Hernández-Mitre MP; Morpeth SC; Venkatesh B; Hills TE; Davis J; Mahar RK; McPhee G; Jones M; Totterdell J; Tong SYC; Roberts JA
Clin Microbiol Infect; 2024 Jun; 30(6):743-754. PubMed ID: 38331253
[TBL] [Abstract][Full Text] [Related]
38. Organotypic lung tissue culture as a preclinical model to study host- influenza A viral infection: A case for repurposing of nafamostat mesylate.
Saglam-Metiner P; Yildiz-Ozturk E; Tetik-Vardarli A; Cicek C; Goksel O; Goksel T; Tezcanli B; Yesil-Celiktas O
Tissue Cell; 2024 Apr; 87():102319. PubMed ID: 38359705
[TBL] [Abstract][Full Text] [Related]
39. Influenza A(H1N1)pdm09 virus suppresses RIG-I initiated innate antiviral responses in the human lung.
Wu W; Zhang W; Booth JL; Metcalf JP
PLoS One; 2012; 7(11):e49856. PubMed ID: 23185463
[TBL] [Abstract][Full Text] [Related]
40. Cleavage of influenza a virus hemagglutinin in human respiratory epithelium is cell associated and sensitive to exogenous antiproteases.
Zhirnov OP; Ikizler MR; Wright PF
J Virol; 2002 Sep; 76(17):8682-9. PubMed ID: 12163588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
